Shanghai Bio-heart Biological Technology Co., Ltd. 2185.HK Stock
Shanghai Bio-heart Biological Technology Co., Ltd. Price Chart
Shanghai Bio-heart Biological Technology Co., Ltd. 2185.HK Financial and Trading Overview
Contents
- Shanghai Bio-heart Biological Technology Co., Ltd. Price Chart
- Shanghai Bio-heart Biological Technology Co., Ltd. 2185.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Bio-heart Biological Technology Co., Ltd.
- Q&A For Shanghai Bio-heart Biological Technology Co., Ltd. Stock
| Shanghai Bio-heart Biological Technology Co., Ltd. stock price | 2.24 HKD |
| Previous Close | 5.38 HKD |
| Open | 5.4 HKD |
| Bid | 5.25 HKD x N/A |
| Ask | 5.31 HKD x N/A |
| Day's Range | 5.08 - 5.4 HKD |
| 52 Week Range | 3.65 - 75.55 HKD |
| Volume | 65K HKD |
| Avg. Volume | 525.3K HKD |
| Market Cap | 1.28B HKD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.78 HKD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
2185.HK Valuation Measures
| Enterprise Value | 908.21M HKD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.4470782 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.827 |
Trading Information
Shanghai Bio-heart Biological Technology Co., Ltd. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -90.75% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 75.55 HKD |
| 52 Week Low | 3.65 HKD |
| 50-Day Moving Average | 5.81 HKD |
| 200-Day Moving Average | 21.34 HKD |
2185.HK Share Statistics
| Avg. Volume (3 month) | 525.3K HKD |
| Avg. Daily Volume (10-Days) | 228.64K HKD |
| Shares Outstanding | 236.22M |
| Float | 42.37M |
| Short Ratio | N/A |
| % Held by Insiders | 73.73% |
| % Held by Institutions | 16.33% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.037% |
| Return on Equity (ttm) | -23.67% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -237335008 HKD |
| Net Income Avi to Common (ttm) | -204236000 HKD |
| Diluted EPS (ttm) | -0.94 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 451.32M HKD |
| Total Cash Per Share (mrq) | 1.85 HKD |
| Total Debt (mrq) | 18.11M HKD |
| Total Debt/Equity (mrq) | 1.98 HKD |
| Current Ratio (mrq) | 18.773 |
| Book Value Per Share (mrq) | 3.628 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -140616000 HKD |
| Levered Free Cash Flow (ttm) | -77408376 HKD |
Profile of Shanghai Bio-heart Biological Technology Co., Ltd.
| Country | Hong Kong |
| State | N/A |
| City | Shanghai |
| Address | Building 4 |
| ZIP | N/A |
| Phone | 86 21 6879 8511 |
| Website | https://www.bio-heart.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 54 |
Shanghai Bio-heart Biological Technology Co., Ltd. operates as an interventional cardiovascular device company in the People's Republic of China. The company focuses on the provision of bioresorbable scaffolds (BRS) and renal denervation (RDN) therapies for the treatment of coronary artery diseases and uncontrolled and resistant hypertension. It is developing Bioheart, a BRS system used in percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis 2nd, a multi-electrode RDN product candidate; and drug coated balloon, a sirolimus drug-eluting balloon catheter designed for instent restenosis. The company has collaboration agreements with Terumo (China) Investment Co., Ltd. to conduct clinical trials for Iberis 2nd. Shanghai Bio-heart Biological Technology Co., Ltd. was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.
Q&A For Shanghai Bio-heart Biological Technology Co., Ltd. Stock
What is a current 2185.HK stock price?
Shanghai Bio-heart Biological Technology Co., Ltd. 2185.HK stock price today per share is 2.24 HKD.
How to purchase Shanghai Bio-heart Biological Technology Co., Ltd. stock?
You can buy 2185.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Bio-heart Biological Technology Co., Ltd.?
The stock symbol or ticker of Shanghai Bio-heart Biological Technology Co., Ltd. is 2185.HK.
Which industry does the Shanghai Bio-heart Biological Technology Co., Ltd. company belong to?
The Shanghai Bio-heart Biological Technology Co., Ltd. industry is Biotechnology.
How many shares does Shanghai Bio-heart Biological Technology Co., Ltd. have in circulation?
The max supply of Shanghai Bio-heart Biological Technology Co., Ltd. shares is 251.13M.
What is Shanghai Bio-heart Biological Technology Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shanghai Bio-heart Biological Technology Co., Ltd. PE Ratio is now.
What was Shanghai Bio-heart Biological Technology Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shanghai Bio-heart Biological Technology Co., Ltd. EPS is -0.78 HKD over the trailing 12 months.
Which sector does the Shanghai Bio-heart Biological Technology Co., Ltd. company belong to?
The Shanghai Bio-heart Biological Technology Co., Ltd. sector is Healthcare.